In humans, homozygous and compound heterozygous loss-of-function mutations in TTI2 cause microcephaly, severe intellectual disability, dysmorphic facial features, short stature, speech and movement disorders, and skeletal deformations [81,93–95]. This evidence concerns the gene TTI2 and microcephaly.